Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-09-05
2000-03-07
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514314, 514255, A61K 3147, A61K 31495
Patent
active
060341009
ABSTRACT:
A method for the prophylaxis and treatment of diseases induced by acceleration of secretion of cytokines (e.g. TNF-.alpha., IL-1, IL-6, IL-8, and IFN-.gamma.) which comprises administering a benzoheterocyclic compound of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are lower alkyl and X.sup.1 is halogen, R.sup.3 is lower alkyl, R.sup.4 is hydroxy, and X.sup.2 is halogen, or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 4399134 (1983-08-01), Ishikawa et al.
patent: 4894374 (1990-01-01), Skotnicki et al.
J. Antimicrob. Chemother., 19 (No. 6), pp. 781-790 (1987).
Int. J. Immunopharmacol, 12 (No. 1), pp. 31-36 (1990).
Drug Safety, 6 (No. 1), pp. 8-27 (1991).
J. Chemother., (Florence) 1990, 2)5), pp. 300-305.
J. Antimicrob. Chemother., 1992, 30 (2), pp. 240-242.
J. Infect. Dis., 1985, 152 (4), pp. 811-816.
Antimicrob. Agents Chemother. 1986, 30 (1), pp. 184-186.
Adachi Masakazu
Omori Kazunori
Ono Yukihisa
Tamaoka Hisashi
Criares Theodore J.
Otsuka Pharmaceutical Co. Ltd.
LandOfFree
Method for inhibiting cytokine secretion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting cytokine secretion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting cytokine secretion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363473